Replies to post #416822 on Amarin Corp Plc (AMRN)

[north40000]

According to Dew Diligence, BTValue board, the LLY and NVO weight loss drugs, M….. and O……, cause obese patients to lose not only fat but also lean muscle mass(cells). If true, A’s Vascepa should suffer little impact from those life-time drugs with respect to CVD risk reduction use. I’ve not read/seen that news yet in the side effect profiles of those 2 weight-loss drugs.